{
    "Trade/Device Name(s)": [
        "Simplexa VZV Swab Direct",
        "Simplexa VZV Positive Control Pack"
    ],
    "Submitter Information": "DiaSorin Molecular LLC",
    "510(k) Number": "K192376",
    "Predicate Device Reference 510(k) Number(s)": [
        "K162451"
    ],
    "Regulatory Class": "Class II",
    "Product Code(s)": [
        "PGI",
        "PMN"
    ],
    "Summary Letter Date": "August 28, 2019",
    "Summary Letter Received Date": "August 30, 2019",
    "Submission Date": "November 18, 2019",
    "Regulation Number(s)": [
        "21 CFR 866.3309",
        "21 CFR 866.3920"
    ],
    "Regulation Name(s)": [
        "Herpes Virus Nucleic Acid-Based Cutaneous and Mucocutaneous Lesion Panel",
        "Assayed external control material for microbiology nucleic acid amplification (NAT) assays"
    ],
    "Analyte Class(es)": [
        "virology",
        "microbiology",
        "genetic molecular"
    ],
    "Analyte(s)": [
        "Varicella-zoster virus DNA"
    ],
    "Specimen Type(s)": [
        "Cutaneous lesion swab",
        "Mucocutaneous lesion swab"
    ],
    "Specimen Container(s)": [
        "Universal Transport Medium (UTM)"
    ],
    "Instrument(s)/Platform(s)": [
        "LIAISON MDX",
        "LIAISON MDX Studio Software",
        "Direct Amplification Disc (DAD)"
    ],
    "Method(s)/Technology(ies)": [
        "Real-time PCR",
        "Direct amplification without nucleic acid extraction"
    ],
    "Methodologies": [
        "Real-time PCR",
        "Molecular detection"
    ],
    "Submission Type(s)": [
        "Assay",
        "Control",
        "Kit",
        "System",
        "Reagent",
        "Accessory",
        "Consumable"
    ],
    "Document Summary": "FDA 510(k) summary for DiaSorin Molecular Simplexa VZV Swab Direct real-time PCR assay and positive control pack for qualitative detection of VZV DNA from lesion swabs.",
    "Indications for Use Summary": "Qualitative detection of varicella-zoster virus (VZV) DNA in cutaneous and mucocutaneous lesion swabs from patients with signs and symptoms of VZV infection as an aid in diagnosis; positive control pack for assay QC on the LIAISON MDX instrument.",
    "fda_folder": "Microbiology"
}